queloran 50 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 50 mg - ketiapiini
queloran 150 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 150 mg - ketiapiini
queloran 200 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 200 mg - ketiapiini
queloran 300 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 300 mg - ketiapiini
queloran 400 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 400 mg - ketiapiini
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanooma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
capsibu 200 mg kapseli, pehmeä
sandoz a/s sandoz a/s - ibuprofenum - kapseli, pehmeä - 200 mg - ibuprofeeni
capsibu 400 mg kapseli, pehmeä
sandoz a/s sandoz a/s - ibuprofenum - kapseli, pehmeä - 400 mg - ibuprofeeni
risperdal instasolv 0.5 mg tabletti, suussa hajoava
janssen-cilag oy - risperidonum - tabletti, suussa hajoava - 0.5 mg - risperidoni
risperdal instasolv 1 mg tabletti, suussa hajoava
janssen-cilag oy - risperidonum - tabletti, suussa hajoava - 1 mg - risperidoni